1Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009 [J]. CA Cancer J Clin, 2009, 59 (4): 225-249.
2Schrey6gg J, Weller J, Stargardt T, et al. Cost-effective- ness of hybrid PET/CT for staging of non-small cell lung cancer[ J. J Nucl Med, 2010, 51 ( 11 ):1668-1675.
3Puls R, Kuhn JP, Ewert R, et al. Whole-body magnetic res- onance imaging for staging of lung cancer[J]. Front Radi- at Ther Oncol, 2010, 42:46-54.
4Tamiya A, Naito T, Ono A, et al. Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more[J]. Lung Cancer, 2011, 71 (2): 173-177.
5Mubarak N, Gaafar R, Shehata S, eta/. A randomized,phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-smaU cell lung cancer [J]. BMC Cancer,2012, 12: 423.
6Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced stage non-small-cell lung cancer [J]. J Clin Oncol, 2008, 26(21): 3543- 3551.
7Scagliotti G, Hanna N, Fossella F, et aL The differential ef- ficacy of pemetrexed according to NSCLC histology: a re- view of two Phase III studies [J]. Oncologist, 2009, 14 (3): 253-263.
10Su SF, Hu YX, Ouyang WW, et aL Overall survival and toxicities regarding thoracic three-dimensional radiothera- py with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study[J]. BMC Cancer, 2013, 13: 474.
2Joan H,Schiller.晚期非小细胞肺癌的化疗// Harver I. Pass,James B. Mitchell, David H. Johnson, et al,主编.Lung Cancer.冯玉麟,刘春涛译.北京:人民卫生出版社,2002:819-832.
3Massarelli E,Andre F,Liu DD,et al. A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small- cell lung cancer. Lung Cancer,2003,39:55-61.
4Loriot Y, Sofia JC, Le Chevalier T. Expanding role of chemotherapy in lung cancer. Annal Oncol,2006,17 Suppl 10: 101-107.
5ASTRO. Proceedings of the American society. Int J Radiat Oncol Biol Phys,2006,66 Suppl 3 : 253-2518.
6ASTRO. Proceedings of the American society. Int J Radiat Oncol Biol Phys,2007,69 Suppl 3 : 257-2589.
7Jett JR,Midthun D, Crowley JJ,et al. 12th World Conference on Lung Cancer. J Thoracic Oncol,2007,2 ( 8 Suppl) : S137-S852.
8Burr M, Wronski M, Arbit E, et al. Resection of brain metastases from non-small cell lung carcinoma. Results of therapy. J Thorac Cardiovasc Surg, 1992,103:399-411.
9Reyes L, Parvez Z, Nemoto T, et al. Adrenalectomy for adrenal metastasis from lung carcinoma. J Surg Oncol, 1990,44:32-34.
10Belderbos JSA, Heemsbergen WD, Jaeger KD, et al. Final results of a phase Ⅰ /Ⅱ dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys ,2006,66 : 126-134.
